Alembic Pharma gets USFDA nod for Acyclovir ointment

The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 per cent, Alembic Pharmaceuticals said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news